Cargando…

Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model

BACKGROUND: Inhibitors of the nuclear enzyme poly (ADP-ribose) polymerase (PARP-1) have been demonstrated to attenuate pathophysiologic conditions associated with oxidative stress, specifically with carbon tetrachloride (CT)-induced hepatotoxicity. SETTINGS AND DESIGN: In this investigation, we eval...

Descripción completa

Detalles Bibliográficos
Autores principales: McCluskey, James D, Sava, Dmytro, Harbison, Stephen C, Muro-Cacho, Carlos A, Giffe, Johnson T, Ping, Xu, Harbison, Raymond D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249858/
https://www.ncbi.nlm.nih.gov/pubmed/22229131
http://dx.doi.org/10.4103/2229-5151.84788
_version_ 1782220398638661632
author McCluskey, James D
Sava, Dmytro
Harbison, Stephen C
Muro-Cacho, Carlos A
Giffe, Johnson T
Ping, Xu
Harbison, Raymond D
author_facet McCluskey, James D
Sava, Dmytro
Harbison, Stephen C
Muro-Cacho, Carlos A
Giffe, Johnson T
Ping, Xu
Harbison, Raymond D
author_sort McCluskey, James D
collection PubMed
description BACKGROUND: Inhibitors of the nuclear enzyme poly (ADP-ribose) polymerase (PARP-1) have been demonstrated to attenuate pathophysiologic conditions associated with oxidative stress, specifically with carbon tetrachloride (CT)-induced hepatotoxicity. SETTINGS AND DESIGN: In this investigation, we evaluated 3 previously untested water-soluble PARP-1 inhibitors, namely, 3-aminobenzamide (ABA), 5-aminoisoquinolinone (AIQ), and N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide HCl (PJ-34) to determine their efficacy in blocking or attenuating CT-induced hepatotoxicity in male imprinting control region (ICR) mice. STATISTICAL ANALYSIS: Indicators of hepatotoxicity were compared with F-tests among groups to determine statistically significant effects. Pearson's correlation coefficients were used to evaluate the correlation between PARP inhibition and the attenuation of hepatotoxicity. RESULTS AND CONCLUSIONS: CT treatment resulted in hepatic cytotoxicity, increased serum transaminase (ALT), lipid peroxidation (MDA), intracellular glutathione (GSH) depletion, increased carbonyl content, and substantially increased PARP-1 activity. CT treatment also produced profound observable hemorrhagic necrosis in the hepatic centrilobular region of ICR mice. Pretreatment with PJ-34, ABA, and AIQ before CT treatment significantly decreased PARP-1 activity in hepatocytes after CT treatment by 3.4, 2.0, and 1.9 times, respectively. Corresponding to this reduction in PARP-1 activity, a significant reduction in the ALT levels and MDA and a reduction in the GSH depletion were observed. Also, there were no visible tissue defects in the liver samples from animals pretreated with individual PARP-1 inhibitors before CT administration. These results demonstrate the efficacy of the 3 previously untested water-soluble PARP-1 inhibitors in attenuating CT-induced hepatocellular toxicity and further characterize the role of PARP-1 activation and oxidative stress among the cascade of events in hepatocellular necrosis induced by CT treatment.
format Online
Article
Text
id pubmed-3249858
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32498582012-01-06 Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model McCluskey, James D Sava, Dmytro Harbison, Stephen C Muro-Cacho, Carlos A Giffe, Johnson T Ping, Xu Harbison, Raymond D Int J Crit Illn Inj Sci Original Article BACKGROUND: Inhibitors of the nuclear enzyme poly (ADP-ribose) polymerase (PARP-1) have been demonstrated to attenuate pathophysiologic conditions associated with oxidative stress, specifically with carbon tetrachloride (CT)-induced hepatotoxicity. SETTINGS AND DESIGN: In this investigation, we evaluated 3 previously untested water-soluble PARP-1 inhibitors, namely, 3-aminobenzamide (ABA), 5-aminoisoquinolinone (AIQ), and N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide HCl (PJ-34) to determine their efficacy in blocking or attenuating CT-induced hepatotoxicity in male imprinting control region (ICR) mice. STATISTICAL ANALYSIS: Indicators of hepatotoxicity were compared with F-tests among groups to determine statistically significant effects. Pearson's correlation coefficients were used to evaluate the correlation between PARP inhibition and the attenuation of hepatotoxicity. RESULTS AND CONCLUSIONS: CT treatment resulted in hepatic cytotoxicity, increased serum transaminase (ALT), lipid peroxidation (MDA), intracellular glutathione (GSH) depletion, increased carbonyl content, and substantially increased PARP-1 activity. CT treatment also produced profound observable hemorrhagic necrosis in the hepatic centrilobular region of ICR mice. Pretreatment with PJ-34, ABA, and AIQ before CT treatment significantly decreased PARP-1 activity in hepatocytes after CT treatment by 3.4, 2.0, and 1.9 times, respectively. Corresponding to this reduction in PARP-1 activity, a significant reduction in the ALT levels and MDA and a reduction in the GSH depletion were observed. Also, there were no visible tissue defects in the liver samples from animals pretreated with individual PARP-1 inhibitors before CT administration. These results demonstrate the efficacy of the 3 previously untested water-soluble PARP-1 inhibitors in attenuating CT-induced hepatocellular toxicity and further characterize the role of PARP-1 activation and oxidative stress among the cascade of events in hepatocellular necrosis induced by CT treatment. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3249858/ /pubmed/22229131 http://dx.doi.org/10.4103/2229-5151.84788 Text en Copyright: © International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
McCluskey, James D
Sava, Dmytro
Harbison, Stephen C
Muro-Cacho, Carlos A
Giffe, Johnson T
Ping, Xu
Harbison, Raymond D
Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model
title Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model
title_full Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model
title_fullStr Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model
title_full_unstemmed Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model
title_short Hepatoprotective effects of select water–soluble PARP inhibitors in a carbon tetrachloride model
title_sort hepatoprotective effects of select water–soluble parp inhibitors in a carbon tetrachloride model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249858/
https://www.ncbi.nlm.nih.gov/pubmed/22229131
http://dx.doi.org/10.4103/2229-5151.84788
work_keys_str_mv AT mccluskeyjamesd hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel
AT savadmytro hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel
AT harbisonstephenc hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel
AT murocachocarlosa hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel
AT giffejohnsont hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel
AT pingxu hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel
AT harbisonraymondd hepatoprotectiveeffectsofselectwatersolubleparpinhibitorsinacarbontetrachloridemodel